Reading path

Reading Mental-Health Evidence With a Clear Eye

This path builds the skills to interpret psychiatry and psychology evidence, from what a symptom questionnaire really measures to how antidepressant trials handle placebo, effect size, and comparison. It is for readers who want to judge claims about depression and anxiety treatments fairly, without either dismissing or overselling them.

The path, step by step

  1. Start where assessment starts, understanding that a common anxiety questionnaire is a severity gauge, not a diagnosis.

  2. Next learn how the rating scales that serve as trial outcomes are scored, since every effect estimate rests on them.

  3. See how a screening recommendation is assembled from evidence, connecting measurement tools to population-level policy.

  4. Confront the large placebo response that shapes every psychiatry trial before interpreting any drug effect.

  5. With placebo in view, learn to read the magnitude of an antidepressant effect rather than just whether it is significant.

  6. Apply that lens to the time course, correcting a common misreading of how quickly these drugs act.

  7. Scale up to comparison by seeing how a network meta-analysis ranks many drugs at once, and what such rankings can and cannot say.

  8. Compare across modalities, weighing therapy against medication using effect sizes and number needed to treat.

  9. Test your appraisal on a popular adjunct, where blinding limits mean the evidence supports a supporting role rather than a cure.

  10. End with the pharmacology of stopping, closing the treatment arc with how the drugs are safely withdrawn.

Back to all reading paths